Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-18 Sale | 2024-01-18 8:23 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 5,468 | $1.1906 | $6,510 | 10,056 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:12 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 860 | $0.89 | $765 | 41,754 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 5:23 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 828 | $1.72 | $1,424 | 42,614 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:10 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 876 | $0.5211 | $456 | 25,762 (Direct) | View |
| 2020-08-14 Sale | 2020-08-17 8:21 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 872 | $0.605 | $528 | 26,638 (Direct) | View |
| 2020-05-15 Sale | 2020-05-18 4:27 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 909 | $0.6268 | $570 | 27,510 (Direct) | View |
| 2020-02-18 Sale | 2020-02-19 6:08 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 888 | $0.8305 | $737 | 28,419 (Direct) | View |
| 2020-01-02 Sale | 2020-01-03 4:06 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 2,239 | $0.9667 | $2,164 | 29,307 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-20 Option Award | 2024-05-21 4:20 pm | N/A 2034-05-19 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 363,000 | $0 | 363,000 (Direct) | View |
| 2024-01-12 Option Award | 2024-01-17 5:04 pm | N/A 2034-01-11 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 81,250 | $0 | 85,524 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:12 pm | N/A 2033-08-09 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 393,750 | $0 | 393,750 (Direct) | View |
| 2023-01-11 Option Award(A) | 2023-01-17 4:13 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-01-11 Option Award | 2023-01-17 4:07 pm | N/A 2033-01-10 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-09 Option Award | 2022-05-11 4:31 pm | N/A 2030-01-20 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 70,000 | $0 | 70,000 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-26 4:11 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 480,000 | $0 | 480,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:57 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 180,000 | $0 | 180,000 (Direct) | View |
| 2020-01-22 Option Award | 2020-01-24 4:11 pm | N/A 2030-01-21 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel | 210,000 | $0 | 210,000 (Direct) | View |